See below from Wikipedia:
Controversy
Hemispherx has on two occasions received warning letters from the FDA regarding its promotion of Ampligen as safe and effective before approval from the FDA.[30][31]
Manuel Asensio, an investment adviser who reports on companies he considers to be overvalued, has criticized Hemispherx and its Ampligen results,[32] alleging a variety of misdemeanors including accusations of refusing to supply Ampligen after clinical trials have ended,[33] and issuing misleading results to widen markets for Ampligen.[32]
In 1998, Hemispherx Biopharma filed a complaint against Asensio and his company, alleging defamation, conspiracy and interference with its business relations through a short selling plot. After a jury rejected the defamation claims against Asensio, a mistrial was declared. Hemispherx announced in 2006 that they anticipated a new trial date to be set.[34]
On November 2, 1999, Mary Schweitzer, a chronic fatigue syndrome patient who had been treated with Ampligen, raised the question of why Ampligen had never been fast-tracked by the US public health authorities at the Chronic Fatigue Syndrome Co-ordinating Committee of the U.S. Department of Health and Human Services.[35]
In June 2009, The Street alleged Hemispherx was "seeking to divert investors' attention away from the delayed approval of Ampligen as a treatment for chronic fatigue syndrome" by issuing three press releases in seven days about research from 2007 into possible applications for Ampligen as a flu vaccine booster. Hemispherx stated that Ampligen could be used against the H1N1 swine flu. The Street also alleged the Hemispherx press releases were misleading because they imply the research had been done in 2009.[12] Hemispherx's attempts to put Ampligen in the H1N1 market were unsuccessful. The company stated they were "shut out of the U.S. government's efforts to stockpile vaccine against the H1N1 flu."[36]
First my disclaimer.... I own the stock....
Second I consider wiki a horrible reference....
<<Hemispherx has on two occasions received warning letters from the FDA regarding its promotion of Ampligen as safe and effective before approval from the FDA.[30][31]>>
HEB isnt the only one who thinks ampligen is both safe and effective.... as far as the warning letters this happened more than a decade ago and since then the fda has issues hundreds of warning letters.... in short no controversy....
Manuel Asensio, an investment adviser who reports on companies he considers to be overvalued, has criticized Hemispherx and its Ampligen results,[32] alleging a variety of misdemeanors including accusations of refusing to supply Ampligen after clinical trials have ended,[33] and issuing misleading results to widen markets for Ampligen.[32]
In 1998, Hemispherx Biopharma filed a complaint against Asensio and his company, alleging defamation, conspiracy and interference with its business relations through a short selling plot. After a jury rejected the defamation claims against Asensio, a mistrial was declared. Hemispherx announced in 2006 that they anticipated a new trial date to be set.[34]
He was a crook ....pure and simple he was found guilty of fraud and lost his securites license....
<<On November 2, 1999, Mary Schweitzer, a chronic fatigue syndrome patient who had been treated with Ampligen, raised the question of why Ampligen had never been fast-tracked by the US public health authorities at the Chronic Fatigue Syndrome Co-ordinating Committee of the U.S. Department of Health and Human Services.[35]>>
The simple fact is that the fda normally doesnt fast track drugs for diseases which do not directly cause death commonly.....
<<In June 2009, The Street alleged Hemispherx was "seeking to divert investors' attention away from the delayed approval of Ampligen as a treatment for chronic fatigue syndrome" by issuing three press releases in seven days about research from 2007 into possible applications for Ampligen as a flu vaccine booster. Hemispherx stated that Ampligen could be used against the H1N1 swine flu. The Street also alleged the Hemispherx press releases were misleading because they imply the research had been done in 2009.[12] Hemispherx's attempts to put Ampligen in the H1N1 market were unsuccessful. The company stated they were "shut out of the U.S. government's efforts to stockpile vaccine against the H1N1 flu."[36][/QUOTE]>>
Here is another crook.... this one works for short sellers....
recall he also said heb would withdraw its nda...... the implication here is that heb had done something wrong......
It was a lie meant to manipulate the share price.....pure and simple.....
IMO for an unsubstantiated comment like that he should be in jail.....
By the way adam the crook wrote that stuff not the street.....
Then adam the crook talks about heb getting shut out of flu vaccine stockpiling.....
How funny..... While showing great promise for h5n1 it was never tested specifically for h1n1..... so it getting closed out for stockpiling shows how clueless adam is.....
If thats the best controversery you have there seems to be little to worry about.....
Frankly it would be better not to pull guys lilke assensio and adam into a medical discussion......
